Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells

Gut

Volumn 63, Issue 6, 2014, Pages 881-890

  Yang, Xue ^a,b,c,d   Song, Jee Hoon ^a,b   Cheng, Yulan ^a   Wu, Wenjing ^a   Bhagat, Tushar ^e   Yu, Yiting ^e   Abraham, John M ^a   Ibrahim, Sariat ^a   Ravich, William ^a   Roland, Bani Chander ^a   Khashab, Mouen ^a   Singh, Vikesh K ^a   Shin, Eun Ji ^a   Yang, Xiao ^c,d   Verma, Amit K ^e   Meltzer, Stephen J ^a,b   Mori, Yuriko ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HNF1A AS1; LONG UNTRANSLATED RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; APOPTOSIS; ARTICLE; CARCINOGENESIS; CARCINOMA CELL; CELL ASSAY; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CHROMATIN ASSEMBLY AND DISASSEMBLY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ESOPHAGEAL ADENOCARCINOMA; G1 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; GENE SILENCING; GENETIC ANALYSIS; H19 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; NUCLEOSOME; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA PROBE; RNA SEQUENCE; SEQUENCE ANALYSIS; UPREGULATION;

CANCER GENETICS; GENE EXPRESSION; OESOPHAGEAL CANCER;

ADENOCARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; RNA, LONG NONCODING; RNA, SMALL INTERFERING; S PHASE CELL CYCLE CHECKPOINTS; UP-REGULATION;

EID: 84899986084     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2013-305266     Document Type: Article

References (54)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
2. Simard EP, Ward EM, Siegel R, et al. Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin 2012;62:118-28.
3. Denlinger CE, Thompson RK. Molecular basis of esophageal cancer development and progression. Surg Clin North Am 2012;92:1089-103.
4. Huarte M, Rinn JL. Large non-coding RNAs: missing links in cancer? Hum Mol Genet 2010;19:R152-61.
5. Guttman M, Donaghey J, Carey BW, et al. lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 2011;477:295-300.
6. Lee JT. Epigenetic regulation by long noncoding RNAs. Science 2012;338:1435-9.
7. Nagano T, Fraser P. No-nonsense functions for long noncoding RNAs. Cell 2011;145:178-81.
8. Karreth FA, Tay Y, Perna D, et al. In vivo identification of tumor-suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma. Cell 2011;147:382-95.
9. Gong C, Maquat LE. lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3′ UTRs via Alu elements. Nature 2011;470:284-8.
10. Chaumeil J, Le Baccon P, Wutz A, et al A novel role for Xist RNA in the formation of a repressive nuclear compartment into which genes are recruited when silenced. Genes Dev 2006;20:2223-37.
11. Rinn JL, Kertesz M, Wang JK, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007;129:1311-23. (Pubitemid 46962090)
12. Gupta RA, Shah N, Wang KC, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010;464:1071-6.
13. Mourtada-Maarabouni M, Pickard MR, Hedge VL, et al. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene 2009;28:195-208.
14. Khaitan D, Dinger ME, Mazar J, et al. The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer Res 2011;71:3852-62.
15. Loewer S, Cabili MN, Guttman M, et al. Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat Genet 2010;42:1113-17.
16. Braconi C, Kogure T, Valeri N, et al. microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene 2011;30:4750-6.
17. Wu W, Bhagat TD, Yang X, et al. Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1-AS1, in Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology 2013;144:956-66.
18. Aggarwal S, Taneja N, Lin L, et al. Indomethacin-induced apoptosis in esophageal adenocarcinoma cells involves upregulation of Bax and translocation of mitochondrial cytochrome C independent of COX-2 expression. Neoplasia 2000;2:346-56.
19. Alvarez H, Koorstra JB, Hong SM, et al . Establishment and characterization of a bona fide Barrett esophagus-associated adenocarcinoma cell line. Cancer Biol Ther 2008;7:1753-5.
20. Cheng Y, Jin Z, Agarwal R, et al . LARP7 is a potential tumor suppressor gene in gastric cancer. Lab Invest 2012;92:1013-19.
21. Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009;37:1-13.
22. Hibi K, Nakamura H, Hirai A, et al . Loss of H19 imprinting in esophageal cancer. Cancer Res 1996;56:480-2. (Pubitemid 26048601)
23. Mendel DB, Crabtree GR. HNF-1, a member of a novel class of dimerizing homeodomain proteins. J Biol Chem 1991;266:677-80. (Pubitemid 21907165)
24. Odom DT, Zizlsperger N, Gordon DB, et al. Control of pancreas and liver gene expression by HNF transcription factors. Science 2004;303:1378-81. (Pubitemid 38269432)
25. Zeng X, Lin Y, Yin C, et al. Recombinant adenovirus carrying the hepatocyte nuclear factor-1alpha gene inhibits hepatocellular carcinoma xenograft growth in mice. Hepatology 2011;54:2036-47.
26. Lussier CR, Brial F, Roy SA, et al. Loss of hepatocyte-nuclear-factor- 1alpha impacts on adult mouse intestinal epithelial cell growth and cell lineages differentiation. PLoS One 2010;5:e12378.
27. van der Meijden CM, Lapointe DS, Luong MX, et al . Gene profiling of cell cycle progression through S-phase reveals sequential expression of genes required for DNA replication and nucleosome assembly. Cancer Res 2002;62:3233-43. (Pubitemid 34602419)
28. Dunleavy EM, Roche D, Tagami H, et al. HJURP is a cell-cycle-dependent maintenance and deposition factor of CENP-A at centromeres. Cell 2009;137:485-97.
29. Lee D, Kwon JH, Kim EH, et al. HMGB2 stabilizes p53 by interfering with E6/E6AP-mediated p53 degradation in human papillomavirus-positive HeLa cells. Cancer Lett 2010;292:125-32.
30. Berteaux N, Lottin S, Monte D, et al. H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. J Biol Chem 2005;280:29625-36. (Pubitemid 41177038)
31. Ryu HH, Jung S, Jung TY, et al. Role of metallothionein 1E in the migration and invasion of human glioma cell lines. Int J Oncol 2012;41:1305-13.
32. Wu Y, Siadaty MS, Berens ME, et al. Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration. Oncogene 2008;27:6679-89.
33. Wang B, Hendricks DT, Wamunyokoli F, et al. A growth-related oncogene/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer. Cancer Res 2006;66:3071-7.
34. Bachmeier BE, Mohrenz IV, Mirisola V, et al. Curcumin downregulates the inflammatory cytokines CXCL1 and -2 in breast cancer cells via NFkappaB. Carcinogenesis 2008;29:779-89. (Pubitemid 351494166)
35. Kim M, Ju H, Lim B, et al. Maspin genetically and functionally associates with gastric cancer by regulating cell cycle progression. Carcinogenesis 2012;33:2344-50.
36. Khalkhali-Ellis Z. Maspin: the new frontier. Clin Cancer Res 2006;12:7279-83. (Pubitemid 46095399)
37. Kim CJ, Song JH, Cho YG, et al. Down-regulation of ATBF1 is a major inactivating mechanism in hepatocellular carcinoma. Histopathology 2008;52:552-9. (Pubitemid 351442655)
38. Sun X, Frierson HF, Chen C, et al. Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer. Nat Genet 2005;37:407-12.
39. Cho YG, Song JH, Kim CJ, et al. Genetic alterations of the ATBF1 gene in gastric cancer. Clin Cancer Res 2007;13:4355-9.
40. Guttman M, Amit I, Garber M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 2009;458:223-7.
41. Wang S, Zhan M, Yin J, et al. Transcriptional profiling suggests that Barrett's metaplasia is an early intermediate stage in esophageal adenocarcinogenesis. Oncogene 2006;25:3346-56. (Pubitemid 43846319)
42. di Pietro M, Lao-Sirieix P, Boyle S, et al. Evidence for a functional role of epigenetically regulated midcluster HOXB genes in the development of Barrett esophagus. Proc Natl Acad Sci USA 2012;109:9077-82.
43. Tian JM, Schibler U. Tissue-specific expression of the gene encoding hepatocyte nuclear factor 1 may involve hepatocyte nuclear factor 4. Genes Dev 1991;5:2225-34.
44. Boulter L, Govaere O, Bird TG, et al. Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat Med 2012;18:572-9.
45. Jung D, Kullak-Ublick GA. Hepatocyte nuclear factor 1 alpha: a key mediator of the effect of bile acids on gene expression. Hepatology 2003;37:622-31. (Pubitemid 36258784)
46. Belanger AS, Tojcic J, Harvey M, et al. Regulation of UGT1A1 and HNF1 transcription factor gene expression by DNA methylation in colon cancer cells. BMC Mol Biol 2010;11:9.
47. Hu Z, Huang G, Sadanandam A, et al. The expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancer. Breast Cancer Res 2010;12:R18.
48. Kato T, Sato N, Hayama S, et al . Activation of Holliday junction recognizing protein involved in the chromosomal stability and immortality of cancer cells. Cancer Res 2007;67:8544-53. (Pubitemid 47437429)
49. Wang W, Jiang H, Zhu H, et al. Overexpression of high mobility group box 1 and 2 is associated with the progression and angiogenesis of human bladder carcinoma. Oncol Lett 2013;5:884-8.
50. Shin YJ, Kim MS, Lee J, et al. High-mobility group box 2 (HMGB2) modulates radioresponse and is downregulated by p53 in colorectal cancer cell. Cancer Biol Ther 2013;14:213-21.
51. Yoshimizu T, Miroglio A, Ripoche MA, et al. The H19 locus acts in vivo as a tumor suppressor. Proc Natl Acad Sci USA 2008;105:12417-22.
52. Lottin S, Adriaenssens E, Dupressoir T, et al. Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells. Carcinogenesis 2002;23:1885-95. (Pubitemid 35355937)
53. Barsyte-Lovejoy D, Lau SK, Boutros PC, et al. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res 2006;66:5330-7. (Pubitemid 43844958)
54. Kondo M, Suzuki H, Ueda R, et al. Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers. Oncogene 1995;10:1193-8. Diseases